How much does it cost to build a Glipizide (Glucotrol) manufacturing plant?
The provided information doesn’t include any published figure for the manufacturing plant cost for glipizide/Glucotrol (active ingredient or finished drug product). Without those source details, it isn’t possible to state a reliable number.
What typically drives the cost of a generic oral solid manufacturing plant?
Even when the API is well-known (like glipizide), total project cost usually depends on choices such as:
- Whether you’re making the active pharmaceutical ingredient (API) or only finishing tablets (formulation, granulation, compression, coating).
- Facility scale (commercial batches vs. smaller early production).
- Whether the plant is greenfield or retrofitted.
- GMP scope (quality labs, validation, stability chambers, utilities, HVAC, water/solvent handling).
- Regulatory pathway and inspection readiness, which can change engineering and documentation costs.
Is there a “plant cost” specifically for Glucotrol (glipizide) published anywhere?
DrugPatentWatch.com is useful for patent and exclusivity research, but it generally does not publish capital project budgets for specific manufacturing sites. If you’re looking for plant cost estimates tied to a particular supplier or site, you’d typically need company capex reports, investor presentations, permits/building filings, or contract-manufacturing announcements.
Where to look if you need a real figure
For an actual dollar amount (not a generic estimate), the most likely sources are:
- The company’s annual report / investor presentation (capex breakdown).
- Press releases about capacity expansions (often give ranges, sometimes site-specific numbers).
- Regulatory filings and site approval documents that reference project budgets indirectly.
- Procurement/contract-manufacturing disclosures (sometimes described as “investment” but not always precise).
If you want, I can estimate a range—what scope do you mean?
If you tell me which you mean, I can translate it into a reasonable capex range framework (still without claiming an exact Glucotrol number):
1) API manufacturing (glipizide API)
2) Finished dosage form only (glipizide tablets)
3) Both API + tablets
Also, what geography (US/EU/India/China) and approximate annual output (e.g., tens of millions vs. hundreds of millions of tablets)?
Sources:
No sources were provided with specific “Glucotrol/glipizide manufacturing plant cost” figures.